Companies
Companies
Game-Changing Merger Creates European CDMO Powerhouse
🔍 Biovian and 3P Biopharmaceuticals merge to create 3PBIOVIAN, a European CDMO offering end-to-end services. 🌍👥🔬🧫🧬💪
Regeneron Joins Forces with 2seventy for Breakthrough Cancer Treatments
Regeneron partners with 2seventy to boost cell therapy pipeline 🤝💼. Aims to develop immune cell therapies for cancer treatment 🧪🔍.
Biogen Pulls Plug on Controversial Alzheimer’s Drug
📢 Biogen discontinues controversial Alzheimer's drug Aduhelm amid mounting criticism and lack of evidence. 💊❌👥
Pfizer’s Bold Investment in Cancer Therapies
📢 Pfizer applauds its big bet in ADCs, a promising cancer treatment area, expecting long-term payoffs and therapeutic advancements. 💪🏥🩺
Cellibre Joins BioMADE: Revolutionizing Sustainable Biomanufacturing
🌱 San Diego-based company Cellibre joins BioMADE for sustainable manufacturing and biomanufacturing innovation. 💰 The White House funds $2 billion for biotechnology. 🤝 Collaboration for lower prices, job creation, and carbon reduction in the US.
Revolutionary Partnership to Enhance mRNA Therapeutics
📢 Lonza and Oxford Nanopore collaborate to advance mRNA Therapeutics! This partnership aims to improve mRNA product analysis 👥🧬💉
German Biopharmaceutical Supplier Targets Korea’s Booming Biomanufacturing Market
📰 Sartorius, a German supplier, targets Korea's biomanufacturing market 🇩🇪👀🇰🇷. Plans to establish sales and production center 🏭📈. Expanding presence in Asian market 🌍👥.
Lonza’s Upcoming Approvals Will Revolutionize CGT Biz in 2024
💼Lonza is looking to strengthen its cell and gene therapy business through upcoming approvals in 2024. 🌟🔬💉💪📈🔒💼🌐
Resilience Teams Up with VGXI for pDNA Supply
Resilience 📢 selects VGXI 🤝 for pDNA supply, fostering promising partnership in the 🧪 biotech industry. Resilience VGXI biotech
Revolutionary Cystic Fibrosis Treatment Secures £26m Funding
📢 Exciting news! Enterprise Therapeutics Ltd has raised £26m for a groundbreaking cystic fibrosis drug trial. 💼🤝👨⚕️
